Inhibition of duck hepatitis B virus replication by interferon‐γ

Interferons have been evaluated extensively as candidate antiviral agents in hepadnaviral infection. We examined the effect of recombinant human interferon‐γ on duck hepatitis B virus replication in human hepatoma cells (Huh 7) transiently transfected with cloned duck hepatitis B virus DNA. Cells transfected in the presence of interferon‐γ display a dose‐dependent reduction in the levels of encapsidated replicative intermediates in the cytoplasm, as judged by Southern blotting of purified viral core DNA. The effect is observed at inferferon‐γ concentrations that do not affect growth rate or viability of Huh 7 cells or their transfection efficiency. Northern analysis of duck hepatitis B virus transcripts in transfected cells demonstrated markedly diminished levels of pre‐ and subgenomic RNA in interferon‐γ‐treated cells. Nuclear run‐on analysis was performed to determine whether these transcripts were diminished due to decreased rates of transcription initiation or increased rates of RNA degradation. Levels of transcription initiation were unaffected by interferon‐γ, implying that duck hepatitis B virus transcripts in interferon‐γ‐treated cells are degraded more rapidly than in untreated cells. © 1993 Wiley‐Liss, Inc.

[1]  G. Moskowitz Wright??s Liver and Biliary Disease , 1994 .

[2]  Roger Williams,et al.  Effect of interferon‐γ on hepatitis B viral antigen expression in primary hepatocyte culture , 1991 .

[3]  H. Varmus,et al.  Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as well as for reverse transcription , 1990, Nature.

[4]  J. Ijzermans,et al.  Interferon-gamma: a review. , 1989, Immunobiology.

[5]  D. Ganem,et al.  A system for studying the selective encapsidation of hepadnavirus RNA , 1989, Journal of virology.

[6]  D. Ganem,et al.  Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication , 1989, Journal of virology.

[7]  K. Koike,et al.  Interferon inhibits hepatitis B virus replication in a stable expression system of transfected viral DNA , 1989, Journal of virology.

[8]  P. Hofschneider,et al.  β- and γ-Interferon in Chronic Active Hepatitis B: A Pilot Trial of Short-Term Combination Therapy , 1989 .

[9]  J. Hoofnagle,et al.  Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B , 1988 .

[10]  D. Ganem,et al.  Replication of duck hepatitis B virus in two differentiated human hepatoma cell lines after transfection with cloned viral DNA. , 1988, Virology.

[11]  J. Summers,et al.  Duck hepatitis B virus (DHBV) particles produced by transient expression of DHBV DNA in a human hepatoma cell line are infectious in vitro , 1988, Journal of virology.

[12]  M. Peters,et al.  Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial. , 1988, Annals of internal medicine.

[13]  J. Bartolomé,et al.  Antiviral effect of recombinant gamma interferon in chronic hepatitis B virus infection: a pilot study. , 1988, Hepato-gastroenterology.

[14]  M. Eghbali,et al.  Differential effects of γ-interferon on collagen and fibronectin gene expression , 1987 .

[15]  J. Cullen,et al.  Experimental transmission of duck hepatitis B virus to pekin ducks and to domestic geese , 1987, Hepatology.

[16]  K. Koike,et al.  Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Falcoff,et al.  Recombinant human interferon-gamma inhibits adenovirus multiplication in vitro. , 1987, The Journal of general virology.

[18]  R. Tjian,et al.  Downstream sequences affect transcription initiation from the adenovirus major late promoter , 1986, Molecular and cellular biology.

[19]  J. Summers,et al.  In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus , 1986, Journal of virology.

[20]  M. Revel,et al.  Interferon-activated genes , 1986 .

[21]  R. Sprengel,et al.  Comparative sequence analysis of duck and human hepatitis B virus genomes , 1985, Journal of medical virology.

[22]  B. Howard,et al.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells , 1982, Molecular and cellular biology.

[23]  B. Rubin,et al.  Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[24]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[25]  H. Johnson,et al.  Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon , 1979, Infection and immunity.

[26]  R. Williams,et al.  Acute viral hepatitis. , 1977, British journal of hospital medicine.

[27]  E. Southern Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.

[28]  T. Takaoka,et al.  An improved synthetic medium suitable for tissue culture of various mammalian cells. , 1975, The Japanese journal of experimental medicine.

[29]  G. Alexander,et al.  Effect of interferon-gamma on hepatitis B viral antigen expression in primary hepatocyte culture. , 1991, Hepatology.

[30]  P. Hofschneider,et al.  Beta- and gamma-interferon in chronic active hepatitis B. A pilot trial of short-term combination therapy. , 1989, Gastroenterology.

[31]  J. Hoofnagle,et al.  Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B. , 1988, Gastroenterology.

[32]  K C Zoon,et al.  Interferons and their actions. , 1987, Annual review of biochemistry.

[33]  H. Varmus,et al.  The molecular biology of the hepatitis B viruses. , 1987, Annual review of biochemistry.

[34]  M. Eghbali,et al.  Differential effects of gamma-interferon on collagen and fibronectin gene expression. , 1987, The Journal of biological chemistry.

[35]  N. Ulker,et al.  Mechanism of interferon action: inhibition of vesicular stomatitis virus replication in human amnion U cells by cloned human gamma-interferon. I. Effect on early and late stages of the viral multiplication cycle. , 1985, The Journal of biological chemistry.

[36]  W P Havens,et al.  Viral hepatitis. , 1970, The Medical clinics of North America.

[37]  A. Rudolph,et al.  Rudolph's Pediatrics , 1969 .